BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23352460)

  • 1. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells.
    Chen D; Ma F; Xu S; Yang S; Chen F; Rong L; Chi Y; Zhao Q; Lu S; Han Z; Pang A; Han Z
    Cytotherapy; 2013 Apr; 15(4):423-33. PubMed ID: 23352460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and role of miR-301a in human umbilical cord-derived mesenchymal stromal cells.
    Ma F; Chen D; Chi Y; Chen F; Li X; Han Z
    Cytotherapy; 2013 Dec; 15(12):1511-6. PubMed ID: 24035358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
    Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
    Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.
    Zhao X; Liu D; Gong W; Zhao G; Liu L; Yang L; Hou Y
    Stem Cells; 2014 Feb; 32(2):521-33. PubMed ID: 24105952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists.
    Chen X; Zhang ZY; Zhou H; Zhou GW
    Dev Growth Differ; 2014 Apr; 56(3):233-44. PubMed ID: 24645700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
    Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
    Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.
    Lebre MC; van der Aar AM; van Baarsen L; van Capel TM; Schuitemaker JH; Kapsenberg ML; de Jong EC
    J Invest Dermatol; 2007 Feb; 127(2):331-41. PubMed ID: 17068485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of toll-like receptors on human adipose-derived stromal cells.
    Hwa Cho H; Bae YC; Jung JS
    Stem Cells; 2006 Dec; 24(12):2744-52. PubMed ID: 16902195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Toll-like receptor 3 and 4 in regulating the function of mesenchymal stem cells isolated from umbilical cord.
    Zhang L; Liu D; Pu D; Wang Y; Li L; He Y; Li Y; Li L; Qiu Z; Zhao S; Li W
    Int J Mol Med; 2015 Apr; 35(4):1003-10. PubMed ID: 25695694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No significant effects of Poly(I:C) on human umbilical cord-derived mesenchymal stem cells in the treatment of B6.MRL-Fas(lpr) mice.
    Huang S; Wang D; Gu F; Zhang Z; Deng W; Chen W; Tang X; Yao G; Feng X; Sun L
    Curr Res Transl Med; 2016; 64(2):55-60. PubMed ID: 27316386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands.
    Alsaleh G; Messer L; Semaan N; Boulanger N; Gottenberg JE; Sibilia J; Wachsmann D
    Arthritis Rheum; 2007 Oct; 56(10):3202-14. PubMed ID: 17907168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.
    Harada K; Isse K; Nakanuma Y
    J Clin Pathol; 2006 Feb; 59(2):184-90. PubMed ID: 16443736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
    Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
    Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
    Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
    Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
    Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
    Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.